Why Don’t Immune Checkpoint Inhibitors Work in Colorectal Cancer?
Why Don’t Immune Checkpoint Inhibitors Work in Colorectal Cancer? Journal of Gastrointestinal Cancer and Stromal Tumors – April 2017 JGCST-02-114
Category Relevant Publications
TLR Adaptor Protein MYD88 Mediates Sensitivity to HDAC Inhibitors via a Cytokine-Dependent Mechanism
TLR Adaptor Protein MYD88 Mediates Sensitivity to HDAC Inhibitors via a Cytokine-Dependent Mechanism Cancer Research – December 2016 New-et-al-Cancer-Research-2016
Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2)
Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2) Lancet – November 2016 Kerr-et-al-Lancet-Oncology-2016-
Evaluation of PIK3CA Mutation As a Predictor of Benefit From Nonsteroidal Anti-Inflammatory Drug Therapy in Colorectal Cancer
Evaluation of PIK3CA Mutation As a Predictor of Benefit From Nonsteroidal Anti-Inflammatory Drug Therapy in Colorectal Cancer. Journal of Clinical Oncology – December 2013 Domingo-et-al-JCO.2013.50
Tailoring treatment and trials to prognosis
Tailoring treatment and trials to prognosis. Nature Reviews – August 2013 Kerr-and-Shi-Nature-Reviews.2013.97
Use of multivariate analysis to suggest a new molecular classification of colorectal cancer
Use of multivariate analysis to suggest a new molecular classification of colorectal cancer Journal of Pathology – 2013 Domingo_et_al-2013-The_Journal_of_Pathology
Predictive biomarkers: a paradigm shift towards personalized cancer medicine
Predictive biomarkers: a paradigm shift towards personalized cancer medicine. Nature Reviews – October 2011 La-Thangue-and-Kerr-Nature-Reviews-2011